Raymond James & Associates’s iShares iBonds Dec 2022 Term Corporate ETF IBDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-618,700
Closed -$15.5M 4155
2022
Q3
$15.5M Buy
618,700
+115,442
+23% +$2.89M 0.02% 734
2022
Q2
$12.6M Buy
503,258
+18,898
+4% +$473K 0.01% 843
2022
Q1
$12.1M Buy
484,360
+66,260
+16% +$1.66M 0.01% 971
2021
Q4
$10.5M Buy
418,100
+20,585
+5% +$519K 0.01% 1074
2021
Q3
$10.1M Sell
397,515
-538
-0.1% -$13.6K 0.01% 1052
2021
Q2
$10.1M Sell
398,053
-7,052
-2% -$179K 0.01% 1063
2021
Q1
$10.3M Buy
405,105
+19,457
+5% +$496K 0.01% 1022
2020
Q4
$9.86M Buy
385,648
+61,810
+19% +$1.58M 0.01% 955
2020
Q3
$8.3M Buy
323,838
+4,033
+1% +$103K 0.01% 954
2020
Q2
$8.21M Sell
319,805
-961
-0.3% -$24.4K 0.01% 926
2020
Q1
$7.95M Buy
320,766
+18,315
+6% +$460K 0.01% 837
2019
Q4
$7.65M Buy
302,451
+4,422
+1% +$112K 0.01% 1020
2019
Q3
$7.55M Buy
298,029
+12,930
+5% +$326K 0.01% 1004
2019
Q2
$7.19M Buy
285,099
+61,310
+27% +$1.53M 0.01% 1028
2019
Q1
$5.58M Buy
223,789
+74,850
+50% +$1.84M 0.01% 1134
2018
Q4
$3.6M Buy
148,939
+10,423
+8% +$252K 0.01% 1268
2018
Q3
$3.37M Buy
138,516
+18,396
+15% +$448K 0.01% 1466
2018
Q2
$2.92M Sell
120,120
-15,356
-11% -$374K ﹤0.01% 1522
2018
Q1
$3.32M Buy
135,476
+43,849
+48% +$1.08M 0.01% 1387
2017
Q4
$2.29M Buy
91,627
+12,146
+15% +$305K ﹤0.01% 1605
2017
Q3
$2.01M Buy
79,481
+57,239
+257% +$1.44M ﹤0.01% 1648
2017
Q2
$560K Buy
22,242
+9,711
+77% +$244K ﹤0.01% 2344
2017
Q1
$312K Buy
+12,531
New +$311K ﹤0.01% 2678

Other funds holding IBDN

Raymond James & Associates's IBDN Position: Q4 2022 in Review

Raymond James & Associates sold out of iShares iBonds Dec 2022 Term Corporate ETF (IBDN) in Q4 2022, closing a stake of 618,700 shares — an estimated $15.5M sold.

Raymond James & Associates first reported a position in IBDN in Q1 2017 and held it in 23 quarters. The position peaked at $15.5M in Q3 2022. 2 funds tracked by Wall St. Rank hold IBDN as of Q4 2022.

  • Raymond James & Associates reported no remaining iShares iBonds Dec 2022 Term Corporate ETF position as of Q4 2022 after selling out during the quarter.
  • Raymond James & Associates sold 618,700 iShares iBonds Dec 2022 Term Corporate ETF shares in Q4 2022, an estimated $15.5M.
  • Raymond James & Associates first reported a position in iShares iBonds Dec 2022 Term Corporate ETF in Q1 2017 and held it in 23 quarters.
  • Raymond James & Associates's iShares iBonds Dec 2022 Term Corporate ETF position peaked at $15.5M in Q3 2022.
  • 2 funds tracked by Wall St. Rank held iShares iBonds Dec 2022 Term Corporate ETF as of Q4 2022.

Based on Raymond James & Associates's 13F filing for Q4 2022, filed 8 Feb 2023.